Laboratorios Farmaceuticos Rovi, S.A. (LON:0ILL)
London · Delayed Price · Currency is GBP · Price in EUR 77.35
+0.50 (0.65%)
Feb 12, 2026, 4:29 PM GMT
LON:0ILL Revenue
Laboratorios Farmaceuticos Rovi had revenue of 210.47M EUR in the quarter ending September 30, 2025, a decrease of -10.54%. This brings the company's revenue in the last twelve months to 724.20M, down -9.39% year-over-year. In the year 2024, Laboratorios Farmaceuticos Rovi had annual revenue of 763.75M, down -7.93%.
Revenue (ttm)
724.20M EUR
Revenue Growth
-9.39%
P/S Ratio
5.43
Revenue / Employee
330.99K EUR
Employees
2,188
Market Cap
3.43B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 763.75M | -65.76M | -7.93% |
| Dec 31, 2023 | 829.51M | 11.81M | 1.44% |
| Dec 31, 2022 | 817.70M | 169.02M | 26.06% |
| Dec 31, 2021 | 648.68M | 228.72M | 54.46% |
| Dec 31, 2020 | 419.96M | 38.65M | 10.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| CVS Group | 673.20M |
| Genus | 672.80M |
Laboratorios Farmaceuticos Rovi News
- 4 months ago - Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Acquisition Of An Injectable Drug Product Manufacturing Site In Phoenix, Arizona Call (Transcript) - Seeking Alpha
- 4 months ago - Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Shareholder/Analyst Call Transcript - Seeking Alpha
- 7 months ago - Laboratorios Farmaceuticos Rovi, S.A. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 7 months ago - Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Laboratorios Farmaceuticos Rovi SA (WBO:ROVI) Q4 2024 Earnings Call Highlights: Navigating ... - GuruFocus
- 1 year ago - Laboratorios Farmaceuticos Rovi, S.A. (LABFF) 2024 Financial Results Earnings Call Transcript - Seeking Alpha